Patents only are worth anything when there is an actual money generating product to protect. I am not sure if there is any other biotech who is actively exploring MANF. As far as we know, no major BP has any interest in MANF. Otherwise we would have seen some type deal by now.
This is Geraldo's last stand. If he can't find a path to after this restructure, me thinks AMarantus is a goner for good and Geraldo will have to use his Tesla for his full time UBER job.
Market Data 
Markets 
AI
